Chris Long and his wife, Janet, were thrilled when he became the first patient at MUSC Health to receive the Alzheimer’s drug ...

Leqembi is expected to grow slowly – in part as a result of the negative hangover in sentiment that surrounded Aduhelm’s approval on controversial data, but also due to logistical hurdles ...

Eisai makes it clear that the intention is in part to help support the rollout of Biogen-partnered Leqembi (lecanemab), the first disease-modifying treatment for Alzheimer’s disease, which was ...